Highly multiplexed allogeneic CAR T-cell engineering using in process DNA-PK inhibition

Authors

• Marielle Summers, Bristol Myers Squibb, USAFollow
• Jenna Fernandez, Cell Therapy, Bristol Myers Squibb, 400 Dexter Ave. N Seattle, WA 98109
• Yen Ho, Cell Therapy, Bristol Myers Squibb, 400 Dexter Ave. N Seattle, WA 98109
• Cédric Cleyrat, Cell Therapy, Bristol Myers Squibb, 400 Dexter Ave. N Seattle, WA 98109
• Ashley Thelen, Cell Therapy, Bristol Myers Squibb, 400 Dexter Ave. N Seattle, WA 98109

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Marielle Summers, Jenna Fernandez, Yen Ho, Cédric Cleyrat, and Ashley Thelen, "Highly multiplexed allogeneic CAR T-cell engineering using in process DNA-PK inhibition" in "Advancing Manufacture of Cell and Gene Therapies IX [2026]", John Moscariello, Neuvogen, USA Corinne Hoesli, McGill University, Canada Bruno Marques, Century Therapeutics, USA Eds, ECI Symposium Series, (2026). https://dc.engconfintl.org/cell_gene_therapies_ix/86